Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes

Endocrinology

Volumn 147, Issue 7, 2006, Pages 3484-3500

  Burrows, C ^a   Holly, J M P ^a   Laurence, N J ^a   Vernon, E G ^a   Carter, J V ^a   Clark, M A ^a   McIntosh, J ^a   McCaig, C ^a   Winters, Z E ^a   Perks, C M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BETA1 INTEGRIN; CAVEOLIN 1; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; BREAST CARCINOMA; BREAST CELL; BREAST EPITHELIUM; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, CD29; APOPTOSIS; BREAST; BREAST NEOPLASMS; CAVEOLIN 1; CELL LINE, TUMOR; CHOLESTEROL; DETERGENTS; DISEASE PROGRESSION; FIBRONECTINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; PHOSPHORYLATION; TRANSFERRIN;

EID: 33745149031     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0005     Document Type: Article

References (53)

1. Pollak MN, Schernhammer ES, Hankinson SE 2004 Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505-518
2. Perks CM, McCaig C, Clarke JB, Clemmons DR, Holly JM 2002 A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells. Biochem Biophys Res Commun 294:988-994
3. Perks C, Holly J 2003 Actions of IGFBP on epithelial cancer cells: potential for new therapeutic targets. Horm Metab Res 35:828-835
4. Rajah R, Valentinis B, Cohen P 1997 Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272:12181-12188
5. Gill ZP, Perks CM, Newcomb PV, Holly JM 1997 Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem 272:25602-25607
6. Williams AC, Collard TJ, Perks CM, Newcomb P, Moorghen M, Holly JM, Paraskeva C 2000 Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res 60:22-27
7. Hollowood AD, Lai T, Perks CM, Newcomb PV, Alderson D, Holly JM 2000 IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int J Cancer 88:336-341
8. Baxter RC 2001 Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 54:145-148
9. Takaoka M, Harada H, Andl CD, Oyama K, Naomoto Y, Dempsey KL, Klein-Szanto AJ, El-Deiry WS, Grimberg A, Nakagawa H 2004 Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3. Cancer Res 64:7711-7723
10. Martin JL, Baxter RC 1999 Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells. J Biol Chem 274:16407-16411
11. Lee HY, Moon H, Chun KH, Chang YS, Hassan K, Ji L, Lotan R, Khuri FR, Hong WK 2004 Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells. J Natl Cancer Inst 96:1536-1548
12. Kansra S, Ewton DZ, Wang J, Friedman E 2000 IGFBP-3 mediates TGF-β1 proliferative response in colon cancer cells. Int J Cancer 87:373-378
13. Martin JL, Pattison SL 2000 Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells. Endocrinology 141:2401-2409
14. Cohen P, Rajah R, Rosenbloom J, Herrick DJ 2000 IGFBP-3 mediates TGF-β1-induced cell growth in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 278:L545-L551
15. Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D 1996 Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88:601-606
16. Vestey SB, Perks CM, Sen C, Calder CJ, Holly JM, Winters ZE 2005 Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome. Breast Cancer Res 7:R119-R129
17. McCaig C, Fowler CA, Laurence NJ, Lai T, Savage PB, Holly JM, Perks CM 2002 Differential interactions between IGFBP-3 and transforming growth factor-β (TGF-β) in normal vs cancerous breast epithelial cells. Br J Cancer 86:1963-1969
18. McCaig C, Perks CM, Holly JM 2002 Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J Cell Sci 115:4293-4303
19. Hollowood AD, Stewart CE, Perks CM, Pell JM, Lai T, Alderson D, Holly JM 2002 Evidence implicating a mid-region sequence of IGFBP-3 in its specific IGF-independent actions. J Cell Biochem 86:583-589
20. Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC 1990 Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086
21. Perks CM, Bowen S, Gill ZP, Newcomb PV, Holly JM 1999 Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells. J Cell Biochem 75:652-664
22. Maile LA, Imai Y, Clarke JB, Clemmons DR 2002 Insulin-like growth factor I increases αVβ3 affinity by increasing the amount of integrin-associated protein that is associated with non-raft domains of the cellular membrane. J Biol Chem 277:1800-1805
23. Perks CM, McCaig C, Holly JM 2000 Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria. J Cell Biochem 80:248-258
24. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP, Cohen P 2004 Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279:469-476
25. Singh B, Charkowicz D, Mascarenhas D 2004 Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3. J Biol Chem 279:477-487
26. Maile LA, Gill ZP, Perks CM, Holly JM 1999 The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells. Endocrinology 140:4040-4045
27. Oh Y, Muller HL, Pham H, Lamson G, Rosenfeld RG 1992 Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IGFBP)-3 in Hs578T human breast cancer cells. Endocrinology 131:3123-3125
28. Weinzimer SA, Gibson TB, Collett-Solberg PF, Khare A, Liu B, Cohen P 2001 Transferrin is an insulin-like growth factor-binding protein-3 binding protein. J Clin Endocrinol Metab 86:1806-1813
29. Assoian RK 1997 Anchorage-dependent cell cycle progression. J Cell Biol 136:1-4
30. Sakai T, Larsen M, Yamada KM 2003 Fibronectin requirement in branching morphogenesis. Nature 423:876-881
31. Castronovo V, Sobel ME 1990 Laminin and fibronectin increase the steady state level of the 67 kD high affinity metastasis-associated laminin receptor mRNA in human cancer cells. Biochem Biophys Res Commun 168:1110-1117
32. Oda K, Hori S, Itoh H, Osamura RY, Tokuda Y, Kubota M, Tajima T 1992 Immunohistochemical study of transforming growth factor β, fibronectin, and fibronectin receptor in invasive mammary carcinomas. Acta Pathol Jpn 42:645-650
33. Brown DA, London E 2000 Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275:17221-17224
34. Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA 1999 A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol 144:1285-1294
35. Berman AE, Kozlova NI, Morozevich GE 2003 Integrins: structure and signaling. Biochemistry (Mosc) 68:1284-1299
36. Yamanaka Y, Fowlkes JL, Wilson EM, Rosenfeld RG, Oh Y 1999 Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology 140:1319-1328
37. Fanayan S, Firth SM, Butt AJ, Baxter RC 2000 Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-β (TGF-β) and the type II TGF-β receptor. J Biol Chem 275:39146-39151
38. Spagnoli A, Torello M, Nagalla SR, Horton WA, Pattee P, Hwa V, Chiarelli F, Roberts Jr CT, Rosenfeld RG 2002 Identification of STAT-1 as a molecular target of IGFBP-3 in the process of chondrogenesis. J Biol Chem 277:18860-18867
39. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P 2000 Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 275:33607-33613
40. 1 integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 142:3214-3222
41. Howlett AR, Bailey N, Damsky C, Petersen OW, Bissell MJ 1995 Cellular growth and survival are mediated by β1 integrins in normal human breast epithelium but not in breast carcinoma. J Cell Sci 108:1945-1957
42. Varner JA, Emerson DA, Juliano RL 1995 Integrin α5β1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell 6:725-740
43. Holly JM, Claffey DC, Cwyfan-Hughes SC, Frost VJ, Yateman ME 1993 Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Regul 3:88-91
44. Maile LA, Holly JM 1999 Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm IGF Res 9:85-95
45. Stewart CE, Newcomb PV, Savage PB, Dickens M, Tavare J, Holly JM 1999 Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis. Growth Horm IGF Res 9:131-142
46. Miranti CK, Brugge JS 2002 Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4:E83-E90
47. Dufourny B, Alblas J, van Teeffelen HA, van Schaik FM, van der Burg B, Steenbergh PH, Sussenbach JS 1997 Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J Biol Chem 272:31163-31171
48. Oh Y, Muller HL, Ng L, Rosenfeld RG 1995 Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 270:13589-13592
49. Perks CM, Newcomb PV, Norman MR, Holly JM 1999 Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. J Mol Endocrinol 22:141-150
50. Gui Y, Murphy LJ 2001 Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma. J Clin Endocrinol Metab 86:2104-2110
51. Campbell PG, Durham SK, Hayes JD, Suwanichkul A, Powell DR 1999 Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin. J Biol Chem 274:30215-30221
52. Perbal B 2001 [The CCN family of cell growth regulators: a new family of normal and pathologic cell growth and differentiation regulators: lessons from the first international workshop on CCN gene family]. Bull Cancer 88:645-649 (French)
53. Lau LF, Lam SC 1999 The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248:44-57